Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral iron supplementation effects on gut microbiome and uremic toxins in predialysis CKD
NL-OMON41855Active, not recruiting
- Sponsor
- Laboratoriumgeneeskunde
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ferrous fumarate in iron deficiency anemia (IDA) and anaemia, sponsored by Laboratoriumgeneeskunde. Primary endpoint: Blood uremic toxin levels. Started Nov 2015; status: active, not recruiting.
02
Drugs
ferrous fumarate
03
Conditions
iron deficiency anemia (IDA)anaemia
Beyond the preview
Go deeper on NL-OMON41855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41855.